Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's New ORA Head, Dara Corrigan, Has Broad Enforcement Experience

This article was originally published in The Pink Sheet Daily

Executive Summary

Former acting HHS inspector general will become associate commissioner for regulatory affairs two years after Margaret O'Keeffe Glavin's retirement.

You may also be interested in...



Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry

Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.

FDA Associate Commissioners Transition As PDUFA IV Rolls Over To V

Peter Lurie will replace David Dorsey as Acting Associate Commissioner for Policy and Planning, and Melinda Plaisier becomes Acting Associate Commissioner for Regulatory Affairs as Dara Corrigan moves to FDA’s European office.

FDA Seeks Speedier Seizure, Injunction Decisions Via Protocol Changes

FDA is working to expedite its decision-making process for seizures and injunctions, which could translate into quicker enforcement actions for violative products.

Related Content

Topics

UsernamePublicRestriction

Register

PS071154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel